• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

74.0400 AUD 0.1600 0.22%

As of 20:33:19 ET on 09/23/2014.

Snapshot for CSL Ltd (CSL)

Open: 73.8500 Day's Range: 73.5700 - 74.3000 Volume: 182,560
Previous Close: 73.8800 52wk Range: 63.7700 - 75.1300 1-Yr Rtn: +16.11%

Stock Chart for CSL

No chart data available.
  • CSL:AU 73.9600
  • 1D
  • 1M
  • 1Y
73.8800
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 24.1829
Estimated P/E(06/2015) 20.9342
Relative P/E vs. AS51 1.3040
Earnings Per Share (USD) (ttm) 2.7014
Est. EPS (USD) (06/2015) 3.1180
Est. PEG Ratio 1.6545
Market Cap (M AUD) 35,154.71
Shares Outstanding (M) 475.84
30 Day Average Volume 1,554,727
Price/Book (mrq) 9.8475
Price/Sale (ttm) 5.9471
Dividend Indicated Gross Yield 1.67%
Cash Dividend (AUD) 0.6485
Dividend Ex-Date 09/08/2014
5 Year Dividend Growth 12.07%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil